Scholarly Commons at Boston University School of Lawmetadata only
Whose Burden, Whose Benefit? Revisiting Ethical Trade-Offs in the WHO Guidelines on Scaling Up Mass Azithromycin Administration
who, world health organization, mdaa, mass drug administration of azithromycin, antimicrobial resistance, amr, health policy, ethics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 277843
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.